Gå til indhold
,
Åbn navigation
eller
Gå til kontaktoplysninger
.
Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markeder
Aktieoversigt
Finanskalender
Research
Artikler
InderesTV
Forum
Q&A
Om os
Fulgte selskaber
Team
Indstillinger
Collapse
Sprog
Copyright © Inderes 2011 - present. All rights reserved.
Search site
Log ind
Log ind
for at modtage meddelelser.
Antti Siltanen
Analytiker
Dækning
Nexstim
BBS-Bioactive Bone Substitutes
Faron Pharmaceuticals
Bioretec
Modulight
Biohit
Orion
Seneste indhold
Viser
Alle indholdstyper
Nexstim: Pressure increased on H2
Analyse
21.08.2023
af
Antti Siltanen
Nexstim
Modulight: Growth not picking up yet
Analyse
21.08.2023
af
Antti Siltanen
Modulight
Nexstim H1 on Friday: Savings sought early in the year
Analytikerkommentar
16.08.2023
af
Antti Siltanen
Nexstim
Nexstim announces agreement on growth financing
Analytikerkommentar
11.08.2023
af
Antti Siltanen
Nexstim
Modulight: Checking estimates ahead of the Q2 report
Analyse
10.08.2023
af
Antti Siltanen
Modulight
Biohit: Positive result from H1 test
Analyse
10.08.2023
af
Antti Siltanen
Biohit
Biohit H1 on Wednesday: Looking East
Analytikerkommentar
04.08.2023
af
Antti Siltanen
Biohit
Nexstim: Changes in partner’s schedules
Analyse
05.07.2023
af
Antti Siltanen
Nexstim
Nightingale reported on its business target achievements for financial year 2022-2023
Analytikerkommentar
04.07.2023
af
Frans-Mikael Rostedt
,
Antti Siltanen
Nightingale Health
Biohit: Preconditions for a turnaround
Video
03.07.2023
af
Antti Siltanen
,
Pia Maljanen
Biohit
Vis flere